Chemical Formula: C27H41N9O7

Chemical Formula C27H41N9O7

Found 26 metabolite its formula value is C27H41N9O7

Gly-Pro-Gly-Arg-Ala-Phe

2-{2-[2-(2-{[1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}acetamido)-5-[(diaminomethylidene)amino]pentanamido]propanamido}-3-phenylpropanoic acid

C27H41N9O7 (603.3128796000001)


   

Asp Lys Arg Trp

(3S)-3-amino-3-{[(1S)-5-amino-1-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]carbamoyl}pentyl]carbamoyl}propanoic acid

C27H41N9O7 (603.3128796000001)


   

Asp Lys Trp Arg

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carboxypropanamido]hexanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C27H41N9O7 (603.3128796000001)


   

Asp Arg Lys Trp

(3S)-3-amino-3-{[(1S)-1-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}pentyl]carbamoyl}-4-carbamimidamidobutyl]carbamoyl}propanoic acid

C27H41N9O7 (603.3128796000001)


   

Asp Arg Trp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]hexanoic acid

C27H41N9O7 (603.3128796000001)


   

Asp Trp Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-indol-3-yl)propanamido]hexanamido]-5-carbamimidamidopentanoic acid

C27H41N9O7 (603.3128796000001)


   

Asp Trp Arg Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]hexanoic acid

C27H41N9O7 (603.3128796000001)


   

Lys Asp Arg Trp

(3S)-3-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]carbamoyl}-3-[(2S)-2,6-diaminohexanamido]propanoic acid

C27H41N9O7 (603.3128796000001)


   

Lys Asp Trp Arg

(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-3-carboxy-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-(1H-indol-3-yl)propanamido]pentanoic acid

C27H41N9O7 (603.3128796000001)


   

Lys Arg Asp Trp

(3S)-3-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C27H41N9O7 (603.3128796000001)


   

Lys Arg Trp Asp

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]-3-(1H-indol-3-yl)propanamido]butanedioic acid

C27H41N9O7 (603.3128796000001)


   

Lys Trp Asp Arg

(2S)-5-carbamimidamido-2-[(2S)-3-carboxy-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-indol-3-yl)propanamido]propanamido]pentanoic acid

C27H41N9O7 (603.3128796000001)


   

Lys Trp Arg Asp

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-indol-3-yl)propanamido]pentanamido]butanedioic acid

C27H41N9O7 (603.3128796000001)


   

Arg Asp Lys Trp

(3S)-3-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}pentyl]carbamoyl}-3-[(2S)-2-amino-5-carbamimidamidopentanamido]propanoic acid

C27H41N9O7 (603.3128796000001)


   

Arg Asp Trp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carboxypropanamido]-3-(1H-indol-3-yl)propanamido]hexanoic acid

C27H41N9O7 (603.3128796000001)


   

Arg Lys Asp Trp

(3S)-3-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C27H41N9O7 (603.3128796000001)


   

Arg Lys Trp Asp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]-3-(1H-indol-3-yl)propanamido]butanedioic acid

C27H41N9O7 (603.3128796000001)


   

Arg Trp Asp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-carboxypropanamido]hexanoic acid

C27H41N9O7 (603.3128796000001)


   

Arg Trp Lys Asp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]hexanamido]butanedioic acid

C27H41N9O7 (603.3128796000001)


   

Trp Asp Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-carboxypropanamido]hexanamido]-5-carbamimidamidopentanoic acid

C27H41N9O7 (603.3128796000001)


   

Trp Asp Arg Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-carboxypropanamido]-5-carbamimidamidopentanamido]hexanoic acid

C27H41N9O7 (603.3128796000001)


   

Trp Lys Asp Arg

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]hexanamido]-3-carboxypropanamido]-5-carbamimidamidopentanoic acid

C27H41N9O7 (603.3128796000001)


   

Trp Lys Arg Asp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]hexanamido]-5-carbamimidamidopentanamido]butanedioic acid

C27H41N9O7 (603.3128796000001)


   

Trp Arg Asp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-carboxypropanamido]hexanoic acid

C27H41N9O7 (603.3128796000001)


   

Trp Arg Lys Asp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]hexanamido]butanedioic acid

C27H41N9O7 (603.3128796000001)


   

Cyclo(-RGDfK)

Cyclo(-RGDfK)

C27H41N9O7 (603.3128796000001)


Cyclo(-RGDfK) is a potent and selective inhibitor of the αvβ3 integrin, with an IC50 of 0.94 nM[1]. Cyclo(-RGDfK) TFA potently targets tumor microvasculature and cancer cells through the specific binding to the αvβ3 integrin on the cell surface[2].